CINECA IRIS Institutional Research Information System

BELLINI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.314
AS - Asia 6.332
EU - Europa 4.566
SA - Sud America 1.115
AF - Africa 286
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.993
SG - Singapore 2.129
CN - Cina 1.829
IT - Italia 1.626
HK - Hong Kong 1.115
BR - Brasile 952
SE - Svezia 657
DE - Germania 465
VN - Vietnam 406
BG - Bulgaria 365
GB - Regno Unito 326
KR - Corea 273
CA - Canada 244
FI - Finlandia 231
RU - Federazione Russa 209
TR - Turchia 177
UA - Ucraina 153
AT - Austria 114
FR - Francia 111
IN - India 99
CI - Costa d'Avorio 90
CH - Svizzera 61
AR - Argentina 60
NL - Olanda 51
JP - Giappone 49
MX - Messico 48
BD - Bangladesh 46
PL - Polonia 46
ES - Italia 39
MA - Marocco 33
ZA - Sudafrica 33
NG - Nigeria 28
BE - Belgio 27
ID - Indonesia 26
CD - Congo 25
EC - Ecuador 25
IQ - Iraq 25
AU - Australia 24
SN - Senegal 23
CO - Colombia 21
MY - Malesia 19
IR - Iran 18
PK - Pakistan 17
EG - Egitto 14
PT - Portogallo 14
SA - Arabia Saudita 14
NO - Norvegia 13
UZ - Uzbekistan 13
PY - Paraguay 12
IE - Irlanda 11
VE - Venezuela 11
LT - Lituania 10
PE - Perù 10
UY - Uruguay 10
CL - Cile 9
GR - Grecia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
KE - Kenya 8
TH - Thailandia 8
TN - Tunisia 8
IL - Israele 7
NP - Nepal 6
PH - Filippine 6
AZ - Azerbaigian 5
JM - Giamaica 5
JO - Giordania 5
PA - Panama 5
PS - Palestinian Territory 5
TW - Taiwan 5
BJ - Benin 4
BO - Bolivia 4
DK - Danimarca 4
GA - Gabon 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
BB - Barbados 3
EU - Europa 3
GE - Georgia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LY - Libia 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 23.627
Salva come PNG Salva come JPEG
Città #
Ashburn 1.383
Hong Kong 1.104
Singapore 1.100
Fairfield 954
Woodbridge 757
Santa Clara 690
Houston 642
Dallas 636
Ann Arbor 590
Serra 582
Chandler 526
Seattle 411
Shanghai 399
Sofia 364
Hefei 355
Cambridge 348
Wilmington 341
Beijing 310
New York 298
San Jose 290
Seoul 265
Boardman 241
Milan 217
Boulder 190
Los Angeles 186
Jacksonville 182
Ottawa 179
Princeton 173
Lawrence 156
Medford 135
London 122
Nanjing 105
Munich 95
Ho Chi Minh City 93
Abidjan 90
São Paulo 89
Helsinki 88
Des Moines 87
Florence 86
Izmir 85
Vienna 81
Dearborn 78
Buffalo 77
Istanbul 74
Dong Ket 71
Redondo Beach 58
Bern 56
San Diego 49
Frankfurt am Main 48
Pisa 44
Turku 44
Nanchang 42
Hanoi 41
Tokyo 41
Council Bluffs 36
Kunming 36
Lucca 35
Jüchen 33
Washington 33
Bremen 31
Belo Horizonte 29
Rome 29
Warsaw 29
Lagos 28
Shenyang 28
Ogden 27
Brussels 26
Nuremberg 26
Redwood City 25
Dakar 23
Phoenix 23
Toronto 23
Casablanca 22
Rio de Janeiro 22
Lubumbashi 21
Tianjin 21
Changsha 20
Chicago 20
Norwalk 20
Montreal 19
Hyderabad 18
Düsseldorf 17
Hebei 17
Brooklyn 16
Campinas 16
Dhaka 16
Falls Church 16
Brasília 15
Columbus 15
Denver 15
Fuzhou 15
Jinan 15
Johannesburg 15
Livorno 15
Massa 15
Orem 15
Quanzhou 15
Guangzhou 14
Lappeenranta 14
Porto Alegre 14
Totale 16.741
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 464
Management of Chronic constipation in general practice 251
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 222
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 220
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 219
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 217
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 210
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 203
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 198
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 197
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 191
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 187
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 186
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 186
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 183
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 181
The general practitioner's approach to irritable bowel syndrome: from intention to practice 181
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 176
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 176
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 176
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 175
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 175
Irritable bowel syndrome and chronic constipation: Fact and fiction 173
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 172
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 172
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 168
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 167
Radionuclide evaluation of the lower gastrointestinal tract 167
Low FODMAP diet: Evidence, doubts, and hopes 166
Alcohol and women: a study in high schools 163
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 163
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 162
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 161
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 159
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 159
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 157
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 155
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 153
A new psychiatric assessment of patients affected with functional gastrointestinal diseases. 151
Esophageal testing: What we have so far 151
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 151
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 149
Pelvic floor dyssynergia and psychiatric disorders. Does the snake bite its tail? 148
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease 148
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 147
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 147
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 147
Alterazioni della motilità colecistica nella distrofia miotonica: valutazione mediante ecotomografia funzionale 146
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 146
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 145
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 142
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 141
Evaluation of latent links between irritable bowel syndrome and sleep quality 141
I farmaci citoprotettivi 140
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 140
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 139
Gastric emptying in myotonic dystrophic patients. 138
Pelvic floor rehabilitation for defecation disorders 138
High Resolution and High Definition Anorectal Manometry 138
Gallbladder motility following intake of mineral bicarbonate-alkaline water. Ultrasonographic assessement 137
null 136
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 136
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 136
Refractory Gastroesophageal Reflux Disease: A Management Update 136
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 135
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 135
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 135
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 134
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 134
Diagnosi e follow-up ecografici di un ematoma splenico 134
Gastrointestinal manifestations in myotonic muscular dystrophy 133
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 133
Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease 131
Can psychiatric evaluation be useful in patients affected with pelvic floor dyssynergia? 131
The genetics of human serotonin transporter and irritable bowel syndrome 130
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 130
Plecanatide for the treatment of chronic idiopathic constipation in adult patients 130
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 130
Double pylorus: report of two cases and review of the literature 129
The general practitioner's management of patients with a new diagnosis of irritable bowel syndrome 129
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 128
Gastroprotezione durante chemioterapia antitumorale: esperienza con farmaci antisecretivi 127
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 127
An extended assessment of bowel habits in a general population 126
Different perception of chronic constipation between patients and gastroenterologists 126
Is a low FODMAP diet dangerous? 126
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 125
Optimal treatment of laryngopharyngeal reflux disease 125
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 122
Post-traumatic inflammatory pseudotumor of the esophagus 122
Relationship of TT virus and Helicobacter pilori infections in gastric tissues of patients with gastritis 122
Can the gamma-glutamyl transpeptidase isoforms really be utilized in the diagnosis of alcoholic liver disease? (multiple letters) [1] 121
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 120
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 120
Velusetrag for the treatment of chronic constipation 120
Difficult defecation in constipated patients: Diagnosis by minimally invasive diagnostic tests 119
Platelet serotonin transporter in diarrhoea predominant irritable bowel syndrome. 119
Is gluten the only culprit for non-celiac gluten/wheat sensitivity? 119
Fecal calprotectin: Current and future perspectives for inflammatory bowel disease treatment 119
The female pelvic floor through midlife and aging. 119
Totale 15.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 0 0 130 80 120 109 74 249
2021/20221.640 18 71 29 95 297 233 77 107 89 48 112 464
2022/20231.968 247 267 181 132 198 255 25 163 327 7 146 20
2023/20241.663 191 132 228 91 200 348 102 52 43 26 68 182
2024/20256.244 142 215 166 359 436 582 461 349 662 835 794 1.243
2025/20265.049 451 1.044 914 835 768 629 408 0 0 0 0 0
Totale 24.131